Related Experiment Video
Updated: Jul 4, 2026
Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
Microglia and myeloperoxidase: a deadly partnership in neurodegenerative disease
Doris L Lefkowitz1, Stanley S Lefkowitz
1School of Biological Sciences, Section of Molecular Genetics and Microbiology, University of Texas at Austin, 1 University Station A5000, Austin, TX 78712-0162, USA. sslefkowitz@yahoo.com
Abstract:
The role of inflammation in Alzheimer's disease, Parkinson's disease, and multiple sclerosis has recently come under increased scrutiny. Associated with these inflammatory responses are tumor necrosis factor-alpha (TNF-alpha) and reactive oxygen species (ROS), both believed to be derived from brain microglia. In addition to the above, the presence of myeloperoxidase (MPO) in these diseased brains has been reported by a number of investigators. However, the possible role of MPO and enzymatically inactive MPO (iMPO) as the "choreographers" of the destruction done by TNF-alpha and ROS is not generally recognized. Previously, our laboratory has reported that MPO/iMPO enhance macrophage generation of ROS and expression of proinflammatory cytokine genes as well as gene products. Recent studies in our laboratory indicate that the same response occurs with microglia. A paradigm is presented for the perpetuation of inflammation associated with neurodegenerative diseases. This model describes the unrecognized consequences of the stimulation of microglia by MPO or iMPO. Both MPO and iMPO and/or its receptor may represent new therapeutic targets for the treatment of these diseases.
Insights
Myeloperoxidase (MPO) and inactive MPO (iMPO) may orchestrate neuroinflammation in Alzheimer's, Parkinson's, and MS by stimulating microglia. Targeting MPO/iMPO offers potential new therapies for these neurodegenerative diseases.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Inflammation is increasingly implicated in neurodegenerative diseases like Alzheimer's, Parkinson's, and multiple sclerosis.
- Tumor necrosis factor-alpha (TNF-alpha) and reactive oxygen species (ROS) are key inflammatory mediators derived from brain microglia.
- Myeloperoxidase (MPO) presence in diseased brains is documented, but its specific role is under-investigated.
Purpose of the Study:
- To investigate the unrecognized role of MPO and enzymatically inactive MPO (iMPO) in neuroinflammation.
- To explore MPO/iMPO as potential "choreographers" of TNF-alpha and ROS-mediated damage in neurodegenerative conditions.
- To present a new paradigm for microglial activation by MPO/iMPO and its consequences.
Main Methods:
- Studies involved examining the effects of MPO/iMPO on microglia.
- Assessed the generation of ROS and expression of proinflammatory cytokine genes and products.
- Utilized a laboratory model to investigate microglial responses.
Main Results:
- MPO/iMPO were found to enhance microglial generation of ROS.
- MPO/iMPO also increased the expression of proinflammatory cytokine genes and gene products in microglia.
- These findings indicate MPO/iMPO stimulate microglia, perpetuating neuroinflammation.
Conclusions:
- MPO and iMPO play a significant, previously unrecognized role in neuroinflammation by stimulating microglia.
- This microglial stimulation leads to increased ROS and pro-inflammatory cytokine production.
- MPO and iMPO, and potentially their receptors, represent novel therapeutic targets for neurodegenerative diseases.
More Related Videos
09:12Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
12:48In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
Published on: May 11, 2015